NCT06121297SLERese-cel
… enabling an ‘immune reset’ with durable responses. RESET-SLE ( NCT06121297) is a Phase 1/2 trial evaluating the safety and efficacy of res…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT06121297 ×
NCT06121297
This institution is selected. Its supporting articles are shown below.